Science Explorer Back to mapMap
Discussion
Researcher · Eureka Therapeutics (United States) · United States

Lucas H. Horan

Lucas H. Horan publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as RNA and protein synthesis mechanisms, CAR-T cell therapy research and RNA modifications and cancer.

ORCID 0000-0002-9143-7667 OpenAlex
World rank
#1,596,260
of 7,710,434 ranked researchers
Rank in United States
#496,855
of 1,627,098
Works
24
Citations
1k
Citations per work
43.4
h-index
8
i10-index 8Top 87% in Molecular Biology
Lucas H. Horan

What does Lucas H. Horan research?

Lucas H. Horan's work is mostly in Biochemistry, Genetics and Molecular Biology (52%), Medicine (22%), Immunology and Microbiology (12%).

Life Sciences: 16 works · 67.5% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 52.5% of their workMolecular Biology: 12 works · 50.0% of their workGenetics: 1 works · 2.5% of their workImmunology and Microbiology: 3 works · 12.5% of their workImmunology: 3 works · 12.5% of their workAgricultural and Biological Sciences: 1 works · 2.5% of their workFood Science: 1 works · 2.5% of their workHealth Sciences: 5 works · 22.5% of their workMedicine: 5 works · 22.5% of their workOncology: 4 works · 17.5% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 5.0% of their workEverything else: 2 works · 10.0% of their workTHEIR WORKLucas H. Horan24works
Life Sciences68%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1352.5%
    2. Immunology and Microbiology312.5%
    3. Agricultural and Biological Sciences12.5%
    1. Medicine522.5%
  3. Everything else210.0%
  1. 1Molecular Biology50% of their works
  2. 2Oncology18% of their works
  3. 3Immunology12% of their works
  4. 4Radiology, Nuclear Medicine and Imaging5% of their works
  5. 5Food Science2% of their works
  6. 6Genetics2% of their works

Research topics

Which keywords describe Lucas H. Horan's research?

The keywords of their largest research topics: Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Ribosome, Translation, m6A-seq, RNA methylation and Alternative Splicing.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Immunotherapy92 topics
  2. CAR T Cells71 topic
  3. Chimeric Antigen Receptor71 topic
  4. Ribosome71 topic
  5. Translation71 topic
  6. RNA methylation61 topic
  7. m6A-seq61 topic
  8. Alternative Splicing51 topic
  9. RNA-Binding Proteins51 topic
  10. Glycosylation42 topics
  11. Dendritic Cells21 topic
  12. Fc Receptors21 topic
  13. Immunity21 topic
  14. Mammalian Cells21 topic
  15. Recombinant Protein21 topic
  16. Therapeutic Antibodies21 topic
  17. Ecosystem Services11 topic
  18. Pollinator Decline11 topic

Where does Lucas H. Horan work?

Lucas H. Horan's main affiliation in the publication record is Eureka Therapeutics (United States), United States.

How many publications and citations does Lucas H. Horan have?

OpenAlex counts 24 works and 1,042 citations for Lucas H. Horan, an h-index of 8, ranking #1,596,260 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lucas H. Horan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.